(1954) Blood 9, 473 Schilling R F (1953) J. Lab. clin. Med. 42, 860 Schilling R F & Schlosser L L (1957) In: Vitamin B1, und Intrinsic Factor. (I Europaisches Symposion tiber Vitamin B,, und Intrinsic Factor, Hamburg, Mai 23-26, 1956.) Ed Brit. med. J. ii, 325, 404 Iron Metabolism Using Iron 59 (59Fe) as a Tracer by Sheila T Callender MD (Oxford) From the point of view of the clinician, as opposed to the research worker, the three most important questions concerning iron are: (1) Is it being absorbed normally? (2) Is it being utilized normally for red cell formation? (3) Is there any abnormal loss? In the absence of gastro-intestinal bleeding there is negligible excretion of iron from the gut in man. If, therefore, a dose of radioactive iron is given by mouth the amount of that dose which is recovered in the faces represents unabsorbed iron, and from this absorption may be calculated. Although total body counting may ultimately be the most favoured technique for assessing iron absorption, at the present time it is impracticable for the normal laboratory, and the fecal test remains the simplest for this purpose.
In the normal subject with normal body stores, some 70% of the labelled iron which is absorbed from a dose of inorganic iron salt is utilized within the following ten to fourteen days for hmmoglobin synthesis. The remainder goes to body stores. In uncomplicated iron deficiency almost all of that absorbed is incorporated within the next few days in new red cells. In simple iron deficiency, therefore, the measurement of incorporation of labelled iron into red cells may be equated with the total iron absorbed; in the normal subject it is only an approximation and always an underestimate. In more complicated aniemias a greater proportion of the dose may be stored rather than utilized and the figures for red cell utilization may be very different from those for absorption. Thus, although red cell utilization of radioactive iron has been widely used by many workers as a measure of iron absorption it is clearly only applicable to certain groups of subjects. Furthermore, we have some evidence that even in iron deficiency, all the iron absorbed from some forms of food may not be used immediately for red cell production (Bannerman & Callender 1961) .
(1) Absorption Much of the earlier work on absorption of radioactive iron was done using oral doses of the order of 1 mg/kg body weight, which is roughly a therapeutic dose. There are clearly advantages in using such a dose if the problem is solely to discover why a patient does not respond to oral iron. Recently, however, there has been a tendency to use a standard dose of 5 mg of iron as being much nearer to the amount which might be found in one meal. As the dose increases, a smaller percentage is absorbed although it represents a larger amount of total iron. Any test of iron absorption must take into account the dose given and, to make experimental observations comparable, a standard amount of iron should be given.
Two of the most important factors concerned in regulating iron absorption are the rate of erythropoiesis and the amount of stored iron. In general, increased erythropoiesis or reduced iron stores increase absorption of iron, whereas depressed erythropoiesis or increased iron stores reduce it. The combined effect of two opposing factors, e.g. increased erythropoiesis and high iron stores, is unpredictable. The state of the iron stores and the erythropoietic activity must therefore be taken into account when interpreting the results of studies of iron absorption.
The scatter values for iron absorption in socalled normal subjects is very wide. High values may well represent states of latent iron deficiency and are particularly liable to be found in female subjects. In apparently normal control subjects in Oxford absorption from a 5 mg dose of ferrous sulphate varied from 10% to 70 %, with a mean of 27 %; subjects who suffered from an uncomplicated iron deficiency absorbed 32 % to 94 %, with a mean of 61 %.
Subjects with malabsorption from idiopathic steatorrhoea are an exception to the rule that diminished iron stores result in increased iron absorption. They absorb much less than normal in spite of their iron deficiency but the malabsorption is corrected by steroids.
We as yet know little about states of relatively poor absorption. Some patients, although not showing the extreme malabsorption of idiopathic steatorrhcea, have a low absorption when considered in the light of their total body needs.
How some iron-deficient subjects can enhance their iron absorption so efficiently, whereas others cannot, is a question for which we have no answer. In general, however, it can be said that, if the absorption of radioactive iron is normal or high in a case of apparently refractory irondeficiency anemia, a particularly careful search should be made for other causes of lack of response to therapy, e.g. excessive iron loss. A good example of this is found in rheumatoid arthritis. Any patients with rheumatoid arthritis and chronic anaemia whom we have tested have shown normal or even high absorption of radioactive iron, depending on their degree of iron deficiency. There now seems to be good evidence that persistence of anemia may often be due to blood loss caused by salicylate therapy (Holt 1960 , Stubbe 1958 .
It is also often said that pregnant women absorb iron poorly, in explanation of the poor response to treatment sometimes seen in iron deficiency during pregnancy. Experimental work using labelled iron in pregnant rabbits has, however, shown that the fcetus, especially near the end of pregnancy, will take precedence over the mother's needs, even though the mother may be iron deficient and the placental transfer of iron has to take place against a concentration gradient (Bothwell et al. 1958) . It seems clear from this that a pregnant woman who is iron deficient may appear refractory to treatment because the bulk of the iron which she absorbs goes through the placenta to supply the ftetus. Some subjects, notably those who have undergone a partial gastrectomy, can absorb inorganic iron salts relatively normally but are unable to absorb food iron (Smith & Mallett 1957 , Stevens et al. 1959 . This serves to illustrate the danger of equating normal iron absorption using organic iron salts with normal physiological absorption of iron.
(2) Utilization ofIron It is more satisfactory to test utilization using an intravenous rather than an oral dose of 59Fe since the intravenous dose gives additional information about the rate of clearance of iron from the plasma. Here certain patterns emerge. Rapid clearance of iron from the plasma occurs for example in iron deficiency, polycythaemia vera and in hiemolytic anemia; slow clearance in hypoplastic anaemia. Poor utilization is seen in such conditions as hypoplastic anemia, hmmochromatosis, hamolytic anemia and good utilization in hypochromic aneemia and polycythwcmia vera. The interpretation of figures which have been obtained from calculation of plasma and red cell iron turnover is subject to considerable debate. It seems probable, however, that the plasma iron turnover reflects total erythropoiesis whereas the red cell utilization reflects the effective erythropoiesis.
One interesting application of plasma iron turnover is in the detection of marrow damage in the absence of amemia. An example of this is the study of Rubin et al. (1958) who found that as many as 5 out of 15 subjects given chloramphenicol showed significant reduction in plasma iron turnover, indicating impairederythropoiesis.
Observations of plasma iron turnover and red cell utilization are sometimes combined with in vivo counting. Although such studies are of interest in revealing the distribution and pathways of the labelled iron, on the whole the various patterns found have so far added little to the interpretation of various types of anemia except perhaps inmyelosclerosis. Heretheremay bea high early splenic uptake, due to myeloid metaplasia, combined with very low counts over the sacrum, indicating diminished marrow activity. Subsequently the splenic counts fall as the labelled red cells are released into the circulation. If there is appreciable heemolysis there may be a secondary rise in splenic counts.
(3) Iron Loss A further important application of radioactive iron is in the investigation of iron loss. For example, it may be used for estimating gastrointestinal blood loss and the blood loss at menstruation. It is extremely difficult to evaluate the menstrual loss from the clinical history alone. Hagedorn et al. (1961) estimated the menstrual loss following an intravenous dose of radioactive iron in 12 non-anaemic women and 15 women with iron deficiency, all of whom considered their menstrual losses to be normal. The non-anemic group lost 6 to 50 ml (mean 37 ml) per period; those with hypochromic anwmia lost 103 to 579 ml (mean 356 ml). Such studies may help to elucidate the problem of the miscalled idiopathic hypochromic anemias in which it is supposed that no abnormal blood loss has occurred.
